03 Oct, 2026

STAT+: FDA names acting heads of drug and vaccine centers to permanent roles

WASHINGTON — The Trump administration permanently filled four key leadership roles at the Food and Drug Administration on Tuesday, after it nominated Heidi Overton to lead the agency late last month.  Three of the officials are serving in an acting capacity, and will take the same roles permanently, the administration said. They are Michael Davis, […]

2 mins read

Novartis’ experimental cardiovascular drug fails a pivotal study

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm and to efforts to target a common heart disease risk factor.  […]

2 mins read

Novartis drug cuts inflammation. A heart outcomes study is to come

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. A newly acquired Novartis drug successfully lowered signs of inflammation in a midstage study, as experts wait to hear how the company plans to advance the drug as a potential cardiovascular treatment.  In […]

2 mins read

STAT+: receptors for three hormones, a monthly obesity drug and a bittersweet ending

You are reading the web edition of STAT’s ADA in 30 Seconds newsletter, from the American Diabetes Association annual conference. Register here Glad to see you again! The American Diabetes Association’s annual conference is in full swing with news about old and new approaches to treating diabetes. Strap in for a recap of Day 2. […]

1 min read

Trump gets more credit than Biden for trying to lower drug prices

WASHINGTON — Controlling drug prices has been a priority for the Trump and Biden administrations. Trump is increasingly recognized for his efforts. A new poll by KFF, a health policy nonprofit, shows that 41% of Americans say it is likely that the Trump administration’s policies will reduce the cost of their prescription drugs. Responses were […]

2 mins read

Marty Makary addresses staff concerns about drug voucher program

WASHINGTON — At an employee-led town hall Tuesday, Food and Drug Administration leaders tried to assuage concerns from within and outside staff about a controversial new program aimed at fast-tracking certain drugs. “This pilot is an effort to make our review processes patient-centered,” said Mallika Mundkur, deputy chief medical officer and manager of the new […]

1 min read

Roche moves obesity drug into pivotal trials after mid-stage success

Andrew Joseph covers health, medicine and the biopharmaceutical industry in Europe. You can reach Andrew on Signal at drawqjoseph.71. Roche plans to launch Phase 3 studies of its lead obesity candidate this quarter after reporting Tuesday that the drug led to significant weight loss in a mid-stage trial. The drug, known as CT-388, caused an […]

1 min read

Trump decides to demand lower drug prices under Medicare

You’re reading the web edition of DC Diagnosis, STAT’s biweekly newsletter on health and medicine policy and politics. Sign up here to receive it in your inbox on Tuesdays and Thursdays. The NIH director started the Pete & Bobby fitness challenge, but I didn’t see Jay Bhattacharya doing pull-ups. And you can decide what you […]

1 min read

Eczema drug Kymera succeeds in first trial, could rival Dupixent

Kymera Therapeutics announced Monday that, for the second time this year, it had successfully completed an early trial of a closely watched drug intended to rival Sanofi and Regeneron’s blockbuster treatment Dupixent. The phase 1 BroADen study enrolled 22 patients with moderate to severe eczema (atopic dermatitis), all of whom took Kymera’s investigational pill, KT-621. […]

1 min read

Trump Administration Joins Medicare Drug Negotiations

WASHINGTON — The Trump administration on Tuesday celebrated drug price reductions it achieved through a program created by Democrats — despite Republicans’ long-standing antipathy toward the policy. The Inflation Reduction Act, a 2022 law supported only by Democrats and signed into law by then-President Biden, allowed the Trump administration to obtain lower prices on 15 […]

9 mins read